The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Meningococcal Conjugate-Global Market Insights and Sales Trends 2024
Synopsis
Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.
The global Meningococcal Conjugate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Meningococcal Conjugate in various end use industries. The expanding demands from the Children, Preteens or Teens and Adults,, are propelling Meningococcal Conjugate market. Menactra, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Menveo segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Meningococcal Conjugate market, driven by demand from China, the second largest economy with some signs of stabilising, the Meningococcal Conjugate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by End User. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Meningococcal Conjugate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Meningococcal Conjugate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Meningococcal Conjugate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Meningococcal Conjugate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Meningococcal Conjugate covered in this report include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc.
The global Meningococcal Conjugate market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed
Novartis
Global Meningococcal Conjugate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Meningococcal Conjugate market, Segment by Type:
Menactra
Menveo
NeisVac-C
Nimenrix
Others
Global Meningococcal Conjugate market, by End User
Children
Preteens or Teens
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Meningococcal Conjugate companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.
The global Meningococcal Conjugate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Meningococcal Conjugate in various end use industries. The expanding demands from the Children, Preteens or Teens and Adults,, are propelling Meningococcal Conjugate market. Menactra, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Menveo segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Meningococcal Conjugate market, driven by demand from China, the second largest economy with some signs of stabilising, the Meningococcal Conjugate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by End User. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Meningococcal Conjugate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Meningococcal Conjugate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Meningococcal Conjugate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Meningococcal Conjugate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Meningococcal Conjugate covered in this report include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc.
The global Meningococcal Conjugate market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed
Novartis
Global Meningococcal Conjugate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Meningococcal Conjugate market, Segment by Type:
Menactra
Menveo
NeisVac-C
Nimenrix
Others
Global Meningococcal Conjugate market, by End User
Children
Preteens or Teens
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Meningococcal Conjugate companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Meningococcal Conjugate
1.1 Meningococcal Conjugate Market Overview
1.1.1 Meningococcal Conjugate Product Scope
1.1.2 Meningococcal Conjugate Market Status and Outlook
1.2 Global Meningococcal Conjugate Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Meningococcal Conjugate Market Size by Region (2018-2029)
1.4 Global Meningococcal Conjugate Historic Market Size by Region (2018-2023)
1.5 Global Meningococcal Conjugate Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Meningococcal Conjugate Market Size (2018-2029)
1.6.1 North America Meningococcal Conjugate Market Size (2018-2029)
1.6.2 Europe Meningococcal Conjugate Market Size (2018-2029)
1.6.3 Asia-Pacific Meningococcal Conjugate Market Size (2018-2029)
1.6.4 Latin America Meningococcal Conjugate Market Size (2018-2029)
1.6.5 Middle East & Africa Meningococcal Conjugate Market Size (2018-2029)
2 Meningococcal Conjugate Market by Type
2.1 Introduction
2.1.1 Menactra
2.1.2 Menveo
2.1.3 NeisVac-C
2.1.4 Nimenrix
2.1.5 Others
2.2 Global Meningococcal Conjugate Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Meningococcal Conjugate Historic Market Size by Type (2018-2023)
2.2.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Meningococcal Conjugate Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Meningococcal Conjugate Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Meningococcal Conjugate Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Meningococcal Conjugate Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Meningococcal Conjugate Revenue Breakdown by Type (2018-2029)
3 Meningococcal Conjugate Market Overview by End User
3.1 Introduction
3.1.1 Children
3.1.2 Preteens or Teens
3.1.3 Adults
3.2 Global Meningococcal Conjugate Market Size by End User: 2018 VS 2022 VS 2029
3.2.1 Global Meningococcal Conjugate Historic Market Size by End User (2018-2023)
3.2.2 Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2029)
3.3 Key Regions Market Size by End User
3.3.1 North America Meningococcal Conjugate Revenue Breakdown by End User (2018-2029)
3.3.2 Europe Meningococcal Conjugate Revenue Breakdown by End User (2018-2029)
3.3.3 Asia-Pacific Meningococcal Conjugate Revenue Breakdown by End User (2018-2029)
3.3.4 Latin America Meningococcal Conjugate Revenue Breakdown by End User (2018-2029)
3.3.5 Middle East and Africa Meningococcal Conjugate Revenue Breakdown by End User (2018-2029)
4 Meningococcal Conjugate Competition Analysis by Players
4.1 Global Meningococcal Conjugate Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)
4.3 Date of Key Players Enter into Meningococcal Conjugate Market
4.4 Global Top Players Meningococcal Conjugate Headquarters and Area Served
4.5 Key Players Meningococcal Conjugate Product Solution and Service
4.6 Competitive Status
4.6.1 Meningococcal Conjugate Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi Pasteur
5.1.1 Sanofi Pasteur Profile
5.1.2 Sanofi Pasteur Main Business
5.1.3 Sanofi Pasteur Meningococcal Conjugate Products, Services and Solutions
5.1.4 Sanofi Pasteur Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Pasteur Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Meningococcal Conjugate Products, Services and Solutions
5.2.4 Pfizer Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 Glaxo Smith Kline
5.3.1 Glaxo Smith Kline Profile
5.3.2 Glaxo Smith Kline Main Business
5.3.3 Glaxo Smith Kline Meningococcal Conjugate Products, Services and Solutions
5.3.4 Glaxo Smith Kline Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.3.5 Hualan Biological Engineering Recent Developments
5.4 Hualan Biological Engineering
5.4.1 Hualan Biological Engineering Profile
5.4.2 Hualan Biological Engineering Main Business
5.4.3 Hualan Biological Engineering Meningococcal Conjugate Products, Services and Solutions
5.4.4 Hualan Biological Engineering Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.4.5 Hualan Biological Engineering Recent Developments
5.5 JN International Medical Corporation
5.5.1 JN International Medical Corporation Profile
5.5.2 JN International Medical Corporation Main Business
5.5.3 JN International Medical Corporation Meningococcal Conjugate Products, Services and Solutions
5.5.4 JN International Medical Corporation Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.5.5 JN International Medical Corporation Recent Developments
5.6 Baxter International
5.6.1 Baxter International Profile
5.6.2 Baxter International Main Business
5.6.3 Baxter International Meningococcal Conjugate Products, Services and Solutions
5.6.4 Baxter International Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.6.5 Baxter International Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Meningococcal Conjugate Products, Services and Solutions
5.7.4 Merck Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Serum Institute of India
5.8.1 Serum Institute of India Profile
5.8.2 Serum Institute of India Main Business
5.8.3 Serum Institute of India Meningococcal Conjugate Products, Services and Solutions
5.8.4 Serum Institute of India Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.8.5 Serum Institute of India Recent Developments
5.9 Biomed
5.9.1 Biomed Profile
5.9.2 Biomed Main Business
5.9.3 Biomed Meningococcal Conjugate Products, Services and Solutions
5.9.4 Biomed Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.9.5 Biomed Recent Developments
5.10 Novartis
5.10.1 Novartis Profile
5.10.2 Novartis Main Business
5.10.3 Novartis Meningococcal Conjugate Products, Services and Solutions
5.10.4 Novartis Meningococcal Conjugate Revenue (US$ Million) & (2018-2023)
5.10.5 Novartis Recent Developments
6 North America
6.1 North America Meningococcal Conjugate Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Conjugate Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Meningococcal Conjugate Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Conjugate Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Meningococcal Conjugate Market Dynamics
11.1 Meningococcal Conjugate Industry Trends
11.2 Meningococcal Conjugate Market Drivers
11.3 Meningococcal Conjugate Market Challenges
11.4 Meningococcal Conjugate Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
